📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: PharmaTher

1.1 - Company Overview

PharmaTher Logo

PharmaTher

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of ketamine-based medicines, developing KETARX (ketamine HCl injection) for anesthesia and procedural sedation via FDA ANDA; a hydrogel microneedle ketamine patch for neuropsychiatric, neurodegenerative and pain disorders; and PD-001, an oral enteric-coated cepharanthine for responsive cancers and infectious diseases.

Products and services

  • Ketamine Patch: PharmaTher architects a hydrogel-forming microneedle patch that delivers ketamine, targeting treatment for neuropsychiatric, neurodegenerative, and pain disorders
  • KETARX™: PharmaTher engineers Ketamine Hydrochloride Injection USP for anesthesia and procedural sedation, aiming for FDA approval via an Abbreviated New Drug Application
  • PD-001: Sairiyo Therapeutics, partly owned by PharmaTher, produces a patented enteric-coated, orally bioavailable cepharanthine formulation for treating responsive cancers and infectious diseases

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to PharmaTher

PHT Logo

PHT

HQ: United States Website
  • Description: Provider of Web-based clinical trial direct data capture and management technologies, including market-leading electronic patient reported outcome (ePRO) solutions used globally in clinical trials. Offers LogPad and StudyPad systems to improve data quality and the StudyWorks online portal providing study sponsors, monitors and sites with real-time access.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PHT company profile →
Pharma Intelligence Logo

Pharma Intelligence

HQ: United Kingdom Website
  • Description: Provider of analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pharma Intelligence company profile →
OmicEra Logo

OmicEra

HQ: Germany Website
  • Description: Provider of proteomics and artificial intelligence (AI) capabilities for medical diagnostics, leveraging high-end mass spectrometry-based proteomics to improve human health, with transparency, reproducible results, and open-source software development at its core.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OmicEra company profile →
Lean Library Logo

Lean Library

HQ: The Netherlands Website
  • Description: Provider of library technology including Lean Library, a browser extension integrating library resources and Open Access alternatives into online workflows; Talis Aspire for structured reading lists and analytics; Talis Elevate for collaborative annotations and engagement insights; Talis CourseFlow for course resource lists; Sciwheel for reference management; and consulting for data migration, system integration, and process optimization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lean Library company profile →
Sware Logo

Sware

HQ: United States Website
  • Description: Provider of a validation automation platform and managed services for life sciences. Res_Q automates and unifies GxP validation to reduce validation time and ensure audit readiness. Managed Services Programs support implementation and management of Res_Q, including training and ongoing compliance assistance. Industry Accelerators via Sware's Marketplace offer over 30 integrated applications to expedite implementation and automate compliance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sware company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for PharmaTher

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to PharmaTher

2.2 - Growth funds investing in similar companies to PharmaTher

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for PharmaTher

4.2 - Public trading comparable groups for PharmaTher

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to PharmaTher

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About PharmaTher

What does PharmaTher do?

PharmaTher is a provider of ketamine-based medicines, developing KETARX (ketamine HCl injection) for anesthesia and procedural sedation via FDA ANDA; a hydrogel microneedle ketamine patch for neuropsychiatric, neurodegenerative and pain disorders; and PD-001, an oral enteric-coated cepharanthine for responsive cancers and infectious diseases.

Who are PharmaTher's competitors?

PharmaTher's competitors and similar companies include PHT, Pharma Intelligence, OmicEra, Lean Library, and Sware.

Where is PharmaTher headquartered?

PharmaTher is headquartered in Canada.

How many employees does PharmaTher have?

PharmaTher has 1,000 employees 🔒.

When was PharmaTher founded?

PharmaTher was founded in 2010 🔒.

What sector and industry vertical is PharmaTher in?

PharmaTher is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for PharmaTher

Who are the top strategic acquirers in PharmaTher's sector and industry

Top strategic M&A buyers and acquirers in PharmaTher's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for PharmaTher?

Top strategic M&A buyers groups and sectors for PharmaTher include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in PharmaTher's sector and industry vertical

Which are the top PE firms investing in PharmaTher's sector and industry vertical?

Top PE firms investing in PharmaTher's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in PharmaTher's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in PharmaTher's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in PharmaTher's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to PharmaTher include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in PharmaTher's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for PharmaTher?

The key public trading comparables and valuation benchmarks for PharmaTher include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for PharmaTher for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for PharmaTher with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in PharmaTher's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for PharmaTher with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in PharmaTher's' sector and industry vertical?

Access recent funding rounds and capital raises in PharmaTher's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for PharmaTher

Launch login modal Launch register modal